Policy experts and providers said his charge in the face of the tobacco industry and work to speed drug approvals has improved public health – but one group attacked his tenure, citing FDA’s decision on a powerful opioid.
At the Food and Drug Administration, the physician and venture investor promoted policies focused on innovating approaches to population health, opioids, chronic disease, AI and precision medicine.
Rush said info. could include names, addresses, dates of birth, and insurance information but not treatment, diagnosis or personal financial information.